Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Adefovir dipivoxil discount card
Is liver function monitoring necessary with lipitor
Enhertu loss of exclusivity patent expiration
Ozempic jordan price 2026
Nicardipine brand names

What was dupixent's revenue in 2019 compared to 2020?

See the DrugPatentWatch profile for dupixent

Roughly in USD, Dupixent’s revenue grew from about $2.3 billion in 2019 to about $6.0 billion in 2020.

If you’d like, I can pull the exact figures (with source citations from Regeneron/Sanofi annual reports) for precise numbers. Would you like me to fetch those?



Other Questions About Dupixent :

Can you specify the quarters with dupixent sales growth in 2020? In which specific quarters did dupixent s sales see a rise in 2020? What percentage of sanofi and regeneron s total revenue did dupixent generate in 2020? In which quarters did dupixent sales increase in 2020? How much revenue did dupixent generate in 2020? How much did dupixent s 2020 revenue increase from the previous year? What were sales of dupixent in 2020?

AI-Drug Label Prescribing Information Alignment Report

Try it Free

Drug Brand Mention Assessment

Branding Score
44
Visibility
56
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

about $3.9 billion in revenue in 2019

Core Claims
  • Dupixent (dupilumab) generated about $3.9 billion in revenue in 2019
  • Dupixent (dupilumab) generated about $4.8 billion in revenue in 2020
  • Dupixent revenue rose by about $0.9 billion from 2019 to 2020
  • That increase is roughly a 23% increase from 2019 to 2020
Differentiators
Pricing Perception: Not Mentioned